+7 year(s) experience
Tom Writes For
By Tom Gallen 15 Jan 2020
Bayer has teamed up with skin microbiome specialist Azitra to develop consumer health products for a host of conditions.
By Tom Gallen 09 Jan 2020
An interactive timeline of HBW Insight's coverage of the blossoming European CBD market in 2019. The timeline covers the main events of the year beginning with the European Commission's decision to classify CBD as a novel food, and ending on the filing of the first application for a synthetic form of the cannabis-derived ingredient.
By Tom Gallen 06 Dec 2019
GSK has launched Flunase in Japan following the switch of fluticasone propionate. JSMI’s Toshi Tominaga gives his assessment of the product’s prospects as an OTC drug.
By Tom Gallen 22 Nov 2019
Aspirational OTC products such as probiotics are outstripping demand for traditional symptom relievers, IQVIA's Andy Tisman told the recent Ceuta International Conference. Consumer health players must adapt their portfolios to cater for the more health conscious, informed, and digitally-connected consumer, Tisman advises
Topic Business Strategies
By Tom Gallen 08 Nov 2019
Recalling Zantac in North America over contamination concerns and tightening regulatory requirements in Europe combined to impede growth at Sanofi Consumer Healthcare in Q3. New CEO Paul Hudson says he is still taking time to get to know the business before making any strategic moves.
Topic Policy and regulation
By Tom Gallen 04 Jul 2019
Maximizing opportunities from digital technology, addressing environmental concerns and responding to the challenges of Brexit are among the Proprietary Association of Great Britain's top priorities as it enters its second century. The association invited guests from around the world to celebrate its centenary at a gala dinner in London on 17 June.
By Tom Gallen 10 Jun 2019
Bayer Consumer Health's sales declined at a single-digit rate in the first quarter of 2019, as the business continued to battle challenges in Europe and the US. Undeterred by this slow start to the year, the German firm says Consumer Health's performance will begin to turnaround in the coming months.
Topic Business strategies